| SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 |
SCHEDULE 13G |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
Sintx Technologies, Inc. (Name of Issuer) |
Common Stock, par value $0.01 per share (Title of Class of Securities) |
829392703 (CUSIP Number) |
07/01/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule
13d-1(b) |
 Rule
13d-1(c) |
| Rule
13d-1(d) |
SCHEDULE 13G |
| CUSIP No. | 829392703 |
| 1 | Names of Reporting Persons Sinaptic Holdings, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 216,450.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 7.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
The reporting person's ownership consists of (i) 216,450 shares of common stock ("Common Stock") and (ii) 325,000 unvested warrants to purchase shares of Common Stock (the "Warrants") that will vest, if at all, upon the achievement of certain performance goals over a four-year period starting July 1, 2025 and subject to a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 19.99% of the Issuer. Because the Warrants are unvested and subject to performance-based vesting goals, which have not yet been achieved, the shares of Common Stock underlying the Warrants are not deemed beneficially owned and have not been included in any of the amounts reported above.
SCHEDULE 13G |
| CUSIP No. | 829392703 |
| 1 | Names of Reporting Persons Sinaptic Surgical, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 216,450.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 7.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
The reporting person's ownership consists of (i) 216,450 shares of Common Stock and (ii) 325,000 unvested Warrants to purchase shares of Common Stock that will vest, if at all, upon the achievement of certain performance goals over a four-year period starting July 1, 2025 and subject to a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 19.99% of the Issuer. Because the Warrants are unvested and subject to performance-based vesting goals, which have not yet been achieved, the shares of Common Stock underlying the Warrants are not deemed beneficially owned and have not been included in any of the amounts reported above.
SCHEDULE 13G |
| Item 1. | ||
| (a) | Name of issuer: Sintx Technologies, Inc. | |
| (b) | Address of issuer's principal executive
offices: 1885 West 2100 South Salt Lake City, UT, 84119 | |
| Item 2. | ||
| (a) | Name of person filing: Sinaptic Holdings, LLC ("Holdings") and Sinaptic Surgical, LLC ("Surgical") (each, a "Reporting Person", and collectively, the "Reporting Persons")
Surgical is the record holder of the shares reported herein. Holdings is the sole member and manager of Surgical. Consequently, it may be deemed the beneficial owner of shares held by Surgical and to have voting and investment control over such shares. | |
| (b) | Address or principal business office or, if
none, residence: The address of each Reporting Person is 591 Brookside Drive, Longmont, CO 80504 | |
| (c) | Citizenship: Each Reporting Person is organized in the State of Delaware. | |
| (d) | Title of class of securities: Common Stock, par value $0.01 per share | |
| (e) | CUSIP No.: 829392703 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | A
parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813); | |
| (i) | A
church plan that is excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | |
| (k) | Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned: Holdings may be deemed to own 216,450 shares of Common Stock owned by Surgical. Surgical is also the record holder of 325,000 unvested Warrants that will vest, if at all, upon the achievement of certain performance goals over a four-year period starting July 1, 2025 and subject to a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 19.99% of the Issuer. Because the Warrants are unvested and subject to performance-based vesting goals, which have not yet been achieved, the shares of Common Stock underlying the Warrants are not deemed beneficially owned and have not been included in any of the amounts reported above. | |
| (b) | Percent of class: Holdings: 7.9%*
Surgical: 7.9%*
*The percentage ownership is determined based on an aggregate 2,725,156 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 2,508,706 shares of Common Stock outstanding as of May 13, 2025, as reported on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on May 15, 2025, and (ii) 216,450 shares of Common Stock owned by Surgical, which have been added to the total shares of Common Stock outstanding. % | |
| (c) | Number of shares as to which the person has: | |
| (i) Sole power to vote or to direct the vote: 0 | ||
| (ii) Shared power to vote or to direct the
vote: 216,450 | ||
| (iii) Sole power to dispose or to direct the
disposition of: 0 | ||
| (iv) Shared power to dispose or to direct the
disposition of: 216,450 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in this statement is
true, complete and correct. |
|
|
|
|
Exhibit
Information |
99.1 Joint Filing Agreement, dated July 1, 2025, between Holdings and Surgical. |